Publicaciones en las que colabora con Santos Castañeda Sanz (28)

2023

  1. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

2019

  1. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

2018

  1. Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review

    Autoimmunity Reviews, Vol. 17, Núm. 3, pp. 301-315

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis /692/699/1670 /692/4023/1670/595 article

    Scientific Reports, Vol. 7, Núm. 1

  3. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Scientific Reports, Vol. 7

  4. Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Scientific reports

2016

  1. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

    American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580

  2. Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients

    PLoS ONE, Vol. 10, Núm. 11

2013

  1. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75

  2. Evidence of association of the NLRP1 gene with giant cell arteritis

    Annals of the Rheumatic Diseases

  3. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

2012

  1. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

2011

  1. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601

  2. Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 5, pp. 889-892

  3. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis

    Human Immunology, Vol. 72, Núm. 5, pp. 458-461

2010

  1. Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis

    Arthritis Research and Therapy, Vol. 12, Núm. 2

  2. Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1 SUPPL. 57